Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Neidhart

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Biomedica Biochimica Acta|January 1, 1989
Adaptation of contractile proteins in human heart and skeletal musclesM C Schaub, U T Brunner, C Von Schulthess, et al.
The Journal of Rheumatology|September 12, 2001
Dual inhibition of 5-lipoxygenase and cyclooxygenases 1 and 2 by ML3000 reduces joint destruction in adjuvant arthritisR E Gay, M Neidhart, F Pataky, et al.
Zeitschrift Fur Rheumatologie|July 17, 1999
[Cartilage oligomeric matrix protein (COMP): the role of a non-collagen cartilage matrix protein as a marker of disease activity and joint destruction in patients with rheumatoid arthritis and osteoarthritis]C Marti, M Neidhart, T Gerber, et al.
Annales De Chirurgie Plastique Et Esthetique|November 28, 2012
[Aesthetic gluteal region reconstruction with a perforator artery flap]C Ho Quoc, F Boucher, P Meeus, et al.
Arthritis and Rheumatism|April 22, 1999
Synovial fluid CD146 (MUC18), a marker for synovial membrane angiogenesis in rheumatoid arthritisM Neidhart, R Wehrli, P Brühlmann, et al.
British Journal of Rheumatology|December 24, 1997
Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradationM Neidhart, N Hauser, M Paulsson, et al.
The Journal of Rheumatology|September 16, 2000
Altered diurnal rhythm of prolactin in systemic sclerosisC Hilty, P Brühlmann, H Sprott, et al.
Schweizerische Medizinische Wochenschrift|September 26, 1992
[Polymyositis: disease course and therapy with intravenously administered immunoglobulins]T Stoll, B A Michel, M Neidhart, et al.
Annals of the Rheumatic Diseases|August 2, 2007
The dual inhibitor of lipoxygenase and cyclooxygenase ML3000 decreases the expression of CXCR3 ligandsC Ospelt, M Kurowska-Stolarska, M Neidhart, et al.
Annals of the Rheumatic Diseases|September 4, 2004
Galectin-3 is induced in rheumatoid arthritis synovial fibroblasts after adhesion to cartilage oligomeric matrix proteinM Neidhart, F Zaucke, R von Knoch, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Biomedica Biochimica Acta|January 1, 1989
Adaptation of contractile proteins in human heart and skeletal musclesM C Schaub, U T Brunner, C Von Schulthess, et al.
The Journal of Rheumatology|September 12, 2001
Dual inhibition of 5-lipoxygenase and cyclooxygenases 1 and 2 by ML3000 reduces joint destruction in adjuvant arthritisR E Gay, M Neidhart, F Pataky, et al.
Zeitschrift Fur Rheumatologie|July 17, 1999
[Cartilage oligomeric matrix protein (COMP): the role of a non-collagen cartilage matrix protein as a marker of disease activity and joint destruction in patients with rheumatoid arthritis and osteoarthritis]C Marti, M Neidhart, T Gerber, et al.
Annales De Chirurgie Plastique Et Esthetique|November 28, 2012
[Aesthetic gluteal region reconstruction with a perforator artery flap]C Ho Quoc, F Boucher, P Meeus, et al.
Arthritis and Rheumatism|April 22, 1999
Synovial fluid CD146 (MUC18), a marker for synovial membrane angiogenesis in rheumatoid arthritisM Neidhart, R Wehrli, P Brühlmann, et al.
British Journal of Rheumatology|December 24, 1997
Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradationM Neidhart, N Hauser, M Paulsson, et al.
The Journal of Rheumatology|September 16, 2000
Altered diurnal rhythm of prolactin in systemic sclerosisC Hilty, P Brühlmann, H Sprott, et al.
Schweizerische Medizinische Wochenschrift|September 26, 1992
[Polymyositis: disease course and therapy with intravenously administered immunoglobulins]T Stoll, B A Michel, M Neidhart, et al.
Annals of the Rheumatic Diseases|August 2, 2007
The dual inhibitor of lipoxygenase and cyclooxygenase ML3000 decreases the expression of CXCR3 ligandsC Ospelt, M Kurowska-Stolarska, M Neidhart, et al.
Annals of the Rheumatic Diseases|September 4, 2004
Galectin-3 is induced in rheumatoid arthritis synovial fibroblasts after adhesion to cartilage oligomeric matrix proteinM Neidhart, F Zaucke, R von Knoch, et al.
Pageof 6